title: [Treatment of viral hepatitis C: what are the perspectives?].
authors.forename: E
authors.initials: E
authors.lastname: Giostra
authors.forename: P J
authors.initials: PJ
authors.lastname: Malè
mesh_terms: D000111:Acetylcysteine / Q000008:administration & dosage; D000328:Adult; D000367:Age Factors; D004359:Drug Therapy, Combination; D005260:Female; D006526:Hepatitis C / Q000628:therapy*; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D007660:Ketoprofen / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012254:Ribavirin / Q000008:administration & dosage; D012737:Sex Factors; D013997:Time Factors; D014580:Ursodeoxycholic Acid / Q000008:administration & dosage
chemical_list: D016898:Interferon-alpha; D012254:Ribavirin; D014580:Ursodeoxycholic Acid; D007660:Ketoprofen; D000111:Acetylcysteine
vernacular_title: Traitement de l'hépatite virale C: quelles perspectives?